Pregnancy Clinical Trial
Official title:
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
This study addresses the intractable challenges of adverse birth outcomes, including preterm
delivery and low birthweight, by proposing the development, implementation and evaluation of
a model of group prenatal care that could be scaled nationally. Group prenatal care models
have been demonstrated through rigorous research to provide significantly improved birth
outcomes with implications for maternal-child health and substantial cost savings. However,
group prenatal care is currently available to only a small fraction of the more than four
million women who give birth annually in the US. Through the development, implementation and
evaluation of a new model of group prenatal care, we will create an outcomes-focused model of
group prenatal care that will be scalable nationally with an eye toward improving US birth
outcomes.
The long-term objective of the proposed study is to reduce the risk for adverse perinatal
outcomes during and after pregnancy among women and families receiving prenatal care in
health centers in 3 geographic locations serving vulnerable populations: Hidalgo County
Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate
a new and improved model of group prenatal care, "Expect with Me," based on our previous
research on group models of prenatal care, which has already yielded favorable behavioral and
biological results in two randomized controlled trials.
We hypothesize that, relative to women who receive standard individual prenatal care, the
women who receive "Expect with Me" group prenatal care will be significantly more likely to:
1. have better perinatal outcomes, including better health behaviors during pregnancy
(e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm
labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum
indicators (e.g., increased breastfeeding);
2. report greater change in risk-related behaviors and psychosocial characteristics that
could be considered potential mechanisms for the program's effectiveness;
3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year
postpartum;
4. have lower healthcare costs through improved outcomes (e.g., appropriate care
utilization, fewer complications, reduced NICU admissions/length of stays)
Comparisons based on propensity-score matched sample of women receiving standard individual
prenatal care at the same clinical sites.
This study addresses the intractable challenges of adverse birth outcomes, including preterm
delivery and low birthweight, by proposing the development, implementation and evaluation of
a model of group prenatal care that could be scaled nationally. Group prenatal care models
have been demonstrated through rigorous research to provide significantly improved birth
outcomes with implications for maternal-child health and substantial cost savings. However,
group prenatal care is currently available to only a small fraction of the more than four
million women who give birth annually in the US. Through the development, implementation and
evaluation of a new model of group prenatal care, we will create an outcomes-focused model of
group prenatal care that will be scalable nationally with an eye toward improving US birth
outcomes.
Specific Aims:
The long-term objective of the proposed study is to reduce the risk for adverse perinatal
outcomes during and after pregnancy among women and families receiving prenatal care in
health centers in 3 geographic locations serving vulnerable populations: Hidalgo County
Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate
a new and improved model of group prenatal care, "Expect with Me," based on our previous
research on group models of prenatal care, which has already yielded favorable behavioral and
biological results in two randomized controlled trials. The overall objective of this project
is to improve maternal health and reduce adverse birth outcomes. We will meet this objective
by achieving three specific goals:
1. Develop a new and improved model of group prenatal care, including curriculum, training
materials, IT infrastructure and marketing materials to support broad adoption of group
prenatal care, enhance consumer experience, monitor patient outcomes, and ensure
national scalability.
2. Implement group prenatal care in three communities at high risk for adverse perinatal
outcomes (Hidalgo County TX, Nashville TN, Detroit MI), engaging and training providers
in group facilitation and the established curriculum, engaging patients through improved
in-reach and outreach strategies, and implementing IT infrastructure to improve uptake,
patient experience, and sustainability through the monitoring of patient outcomes.
3. Evaluate the effect of implementing group prenatal care through a rigorous process and
outcome evaluation that identifies any barriers to national scalability and examines
maternal health and birth outcomes and resultant cost implications.
Specific Study Hypotheses
We hypothesize that, relative to women who receive standard individual prenatal care, the
women who receive "Expect with Me" group prenatal care will be significantly more likely to:
1. have better perinatal outcomes, including better health behaviors during pregnancy
(e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm
labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum
indicators (e.g., increased breastfeeding);
2. report greater change in risk-related behaviors and psychosocial characteristics that
could be considered potential mechanisms for the program's effectiveness;
3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year
postpartum;
4. have lower healthcare costs through improved outcomes (e.g., appropriate care
utilization, fewer complications, reduced NICU admissions/length of stays)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |